Assignee
SINGH BIOTECHNOLOGY LLC
US·5 granted patents·7 pending applications·1 citations·filing 2016–2025
Top patents by PatentIndex Score
12 records- 0181US11951174B2Therapeutics directed against coronavirusSINGH BIOTECHNOLOGY LLC·Filed 2023·Granted Apr 9, 2024·0 cites·5 claims
- 0280US11370847B2Single domain antibodies directed against intracellular antigensSINGH BIOTECHNOLOGY LLC·Filed 2018·Granted Jun 28, 2022·1 cites·5 claims
- 0380US2024238437A1Therapeutics directed against coronavirusSINGH BIOTECHNOLOGY LLC·Filed 2024·Application pending·0 cites
- 0478US2025319197A1Therapeutics directed against coronavirusSINGH BIOTECHNOLOGY LLC·Filed 2025·Application pending·0 cites
- 0572US2022226489A1Therapeutics directed against coronavirusSINGH BIOTECHNOLOGY LLC·Filed 2022·Application pending·0 cites
- 0671US2022089783A1Methods of using single domain antibodies directed against ebola virusSINGH BIOTECHNOLOGY LLC·Filed 2021·Application pending·0 cites
- 0768US11214626B2Single domain antibodies directed against arachidonate 12-lipoxygenaseSINGH BIOTECHNOLOGY LLC·Filed 2019·Granted Jan 4, 2022·0 cites·2 claims
- 0860US10369223B2Single domain antibodies directed against ebola virus VP24SINGH BIOTECHNOLOGY LLC·Filed 2016·Granted Aug 6, 2019·0 cites·2 claims
- 0960US10195277B2Single domain antibodies directed against human immunodeficiency virusSINGH BIOTECHNOLOGY LLC·Filed 2016·Granted Feb 5, 2019·0 cites·2 claims
- 1056US2024101652A1Therapeutic single domain antibodySINGH BIOTECHNOLOGY LLC·Filed 2022·Application pending·0 cites
- 1154US2018072815A1Single Domain Antibodies Directed Against Intracellular AntigensSINGH BIOTECHNOLOGY LLC·Filed 2017·Application pending·0 cites
- 1252US2023279086A1Suppression of uveitis by single domain antibodySINGH BIOTECHNOLOGY LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SINGH BIOTECHNOLOGY LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →